-
1
-
-
0029925182
-
Valproic acid hepatic fatalities. III. US experience since 1986
-
Bryant AE, Dreifuss FE. Valproic acid hepatic fatalities. III. US experience since 1986. Neurology 1996;46:465-9.
-
(1996)
Neurology
, vol.46
, pp. 465-469
-
-
Bryant, A.E.1
Dreifuss, F.E.2
-
2
-
-
0013569157
-
Valproate acid hepatic fatalities: A retrospective review
-
Dreifuss FE, Santilli N, Langer DH, Sweeny KP, Moline BA, Meander KB. Valproate acid hepatic fatalities: a retrospective review. Neurology 1987;37:397-400.
-
(1987)
Neurology
, vol.37
, pp. 397-400
-
-
Dreifuss, F.E.1
Santilli, N.2
Langer, D.H.3
Sweeny, K.P.4
Moline, B.A.5
Meander, K.B.6
-
4
-
-
0006607524
-
Hepatotoxicity of antiepileptic drugs
-
Oxley J, Janz D, Meinardi H, eds. New York: Raven Press
-
Jeavons PM. Hepatotoxicity of antiepileptic drugs. In: Oxley J, Janz D, Meinardi H, eds. Antiepileptic therapy: chronic toxicity of antiepileptic drugs. New York: Raven Press, 1983:1-45.
-
(1983)
Antiepileptic Therapy: Chronic Toxicity of Antiepileptic Drugs
, pp. 1-45
-
-
Jeavons, P.M.1
-
5
-
-
0027973087
-
Severe hepatotoxicity during VPA therapy: An update and review of eight new fatalities
-
König St A, Siemes H, Bläker F, et al. Severe hepatotoxicity during VPA therapy: an update and review of eight new fatalities. Epilepsia 1994;35:1005-15.
-
(1994)
Epilepsia
, vol.35
, pp. 1005-1015
-
-
König, St.A.1
Siemes, H.2
Bläker, F.3
-
6
-
-
0023789945
-
Fatal liver failure in 16 children with valproate therapy
-
Scheffner D, König St A, Rauterberg-Ruland I, Kochen W, Hofmann WJ, Unkelbach ST. Fatal liver failure in 16 children with valproate therapy. Epilepsia 1988;29:530-42.
-
(1988)
Epilepsia
, vol.29
, pp. 530-542
-
-
Scheffner, D.1
König, St.A.2
Rauterberg-Ruland, I.3
Kochen, W.4
Hofmann, W.J.5
Unkelbach, S.T.6
-
7
-
-
0022646267
-
Progressive neuronal degeneration of childhood with liver disease
-
Harding BN, Egger J, Portmann B, Erdohazi M. Progressive neuronal degeneration of childhood with liver disease. Brain 1986; 109:181-206.
-
(1986)
Brain
, vol.109
, pp. 181-206
-
-
Harding, B.N.1
Egger, J.2
Portmann, B.3
Erdohazi, M.4
-
8
-
-
0029688271
-
Abnormalities of glutathione peroxidase and glutathione reductase in four patients with Friedreich's disease
-
Helveston W, Hurd R, Uthman B, Wilder BJ. Abnormalities of glutathione peroxidase and glutathione reductase in four patients with Friedreich's disease. Mov Disord 1996;11:106-7.
-
(1996)
Mov Disord
, vol.11
, pp. 106-107
-
-
Helveston, W.1
Hurd, R.2
Uthman, B.3
Wilder, B.J.4
-
9
-
-
0023024205
-
Valproate toxicity and ornithine carbamoyltransferase deficiency
-
Kay JDS, Hilton-Jones D, Hyman N. Valproate toxicity and ornithine carbamoyltransferase deficiency. Lancet 1986;II:1283-4.
-
(1986)
Lancet
, vol.2
, pp. 1283-1284
-
-
Kay, J.D.S.1
Hilton-Jones, D.2
Hyman, N.3
-
10
-
-
0023226008
-
Tödliches leberversagen bei einem altersgemäß entwickelten jungen unter VPA-monotherapie
-
König St A, Scheffner D, Rauterberg-Ruland I, et al. Tödliches Leberversagen bei einem altersgemäß entwickelten Jungen unter VPA-Monotherapie. Monatschr Kinderheilkd 1987;135:310-3.
-
(1987)
Monatschr Kinderheilkd
, vol.135
, pp. 310-313
-
-
König, St.A.1
Scheffner, D.2
Rauterberg-Ruland, I.3
-
11
-
-
0029075379
-
Plasma and hepatic carnitine and coenzyme A pools in a patient with fatal valproate-induced hepatotoxicity
-
Krähenbühl S, Mang G, Kupferschmidt H, Meier PJ, Krause M. Plasma and hepatic carnitine and coenzyme A pools in a patient with fatal valproate-induced hepatotoxicity. Gut 1995;37:140-3.
-
(1995)
Gut
, vol.37
, pp. 140-143
-
-
Krähenbühl, S.1
Mang, G.2
Kupferschmidt, H.3
Meier, P.J.4
Krause, M.5
-
12
-
-
0013623748
-
Cases of serious/fatal hepatotoxicity due to valproate: Recommended control scheme and preliminary results
-
Oxley J, Janz D, Meinardi H, eds. New York: Raven Press
-
Loyning Y, Johannessen SI, Ritland LS, Strandjord RE, Kloster R. Cases of serious/fatal hepatotoxicity due to valproate: recommended control scheme and preliminary results. In: Oxley J, Janz D, Meinardi H, eds Chronic toxicity of antiepileptic drugs. New York: Raven Press, 1983:47-70.
-
(1983)
Chronic Toxicity of Antiepileptic Drugs
, pp. 47-70
-
-
Loyning, Y.1
Johannessen, S.I.2
Ritland, L.S.3
Strandjord, R.E.4
Kloster, R.5
-
13
-
-
0013623749
-
Hepatic injury with sodium valproate: A reappraisal with special reference to children
-
Rolles CJ. Hepatic injury with sodium valproate: a reappraisal with special reference to children. Br J Clin Pract 1983;727 (suppl.):72-6.
-
(1983)
Br J Clin Pract
, vol.727
, Issue.SUPPL.
, pp. 72-76
-
-
Rolles, C.J.1
-
14
-
-
85069284463
-
Neuronale ceroidlipofuszinose
-
Remschmidt H, Rentz R, Jungmann J, eds. Stuttgart: G. Thieme Verlag
-
Spatz R, Kugler J, Pongratz D. Neuronale Ceroidlipofuszinose. In: Remschmidt H, Rentz R, Jungmann J, eds. Epilepsie 1980. Stuttgart: G. Thieme Verlag, 1982:186-92.
-
(1982)
Epilepsie 1980
, pp. 186-192
-
-
Spatz, R.1
Kugler, J.2
Pongratz, D.3
-
15
-
-
0013569158
-
Valproat-therapie und lebertoxizität
-
Stenzel E, Albani M, Doose H, Penin H, Scheffner D, Schmidt D. Valproat-Therapie und Lebertoxizität. Pädiatr Prax 1987;35:159-63.
-
(1987)
Pädiatr Prax
, vol.35
, pp. 159-163
-
-
Stenzel, E.1
Albani, M.2
Doose, H.3
Penin, H.4
Scheffner, D.5
Schmidt, D.6
-
17
-
-
0031829096
-
Altered antioxidant enzyme activities in children with serious adverse experience related to valproic acid
-
Graf WD, Oleinik OE, Glauser TA, Maertens P, Eder DN, Pippinger CE. Altered antioxidant enzyme activities in children with serious adverse experience related to valproic acid. Neuropediatrics 1998;29:195-201.
-
(1998)
Neuropediatrics
, vol.29
, pp. 195-201
-
-
Graf, W.D.1
Oleinik, O.E.2
Glauser, T.A.3
Maertens, P.4
Eder, D.N.5
Pippinger, C.E.6
-
18
-
-
0025607045
-
Valproate metabolism during hepatotoxicity associated with the drug
-
Eadie MJ, McKinnon GE, Dunstan PR, McLaughlin D, Dickinson RG. Valproate metabolism during hepatotoxicity associated with the drug. Q J Med 1990;284:1229-40.
-
(1990)
Q J Med
, vol.284
, pp. 1229-1240
-
-
Eadie, M.J.1
McKinnon, G.E.2
Dunstan, P.R.3
McLaughlin, D.4
Dickinson, R.G.5
-
20
-
-
0026518432
-
Treatment of valproic acid-associated hepatic failure with orthotopic liver transplantation
-
Bell EA, Shaefer MS, Markin RS, et al. Treatment of valproic acid-associated hepatic failure with orthotopic liver transplantation. Ann Pharmacother 1992;26:18-21.
-
(1992)
Ann Pharmacother
, vol.26
, pp. 18-21
-
-
Bell, E.A.1
Shaefer, M.S.2
Markin, R.S.3
-
21
-
-
0019126596
-
Acute liver failure associated with sodium valproate
-
Ware S, Millward-Sadler GH. Acute liver failure associated with sodium valproate. Lancet 1980;II:1110-3.
-
(1980)
Lancet
, vol.2
, pp. 1110-1113
-
-
Ware, S.1
Millward-Sadler, G.H.2
-
23
-
-
0027196967
-
Unusual electronmicroscopic changes in valproate-associated liver failure
-
Caparros-Lefebvre D, Lecomte-Houcke M, Pruvot FR, Declerck N, Paris JC, Petit H. Unusual electronmicroscopic changes in valproate-associated liver failure. Lancet 1993;41:1604.
-
(1993)
Lancet
, vol.41
, pp. 1604
-
-
Caparros-Lefebvre, D.1
Lecomte-Houcke, M.2
Pruvot, F.R.3
Declerck, N.4
Paris, J.C.5
Petit, H.6
-
24
-
-
0019121946
-
Fatal hepatic failure and sodium valproate
-
Le Bihan A. Fatal hepatic failure and sodium valproate. Lancet 1980;2:1298.
-
(1980)
Lancet
, vol.2
, pp. 1298
-
-
Le Bihan, A.1
|